SCHEMBL175067

SCHEMBL175067

N#Cc1ccc(NC(=O)Nc2cccc3c2CCN3)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
ALDH1A1 P00352 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
LMNA P02545 3/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
NLRP3 Q96P20 1/20 0.49
KDM4E B2RXH2 3/20 0.48
SAE1 Q9UBE0 1/20 0.48
UBA2 Q9UBT2 1/20 0.48
POLB P06746 1/20 0.48
PKM P14618 1/20 0.48
MAPK1 P28482 1/20 0.48
RAB9A P51151 1/20 0.48
IL18 Q14116 1/20 0.48
GAA P10253 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
CXCR2 P25025 2/20 0.46
GLA P06280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175596 0.88 MEN1 (0.56) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL4569778 0.85 MEN1 (0.53) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL174936 0.85 MEN1 (0.51) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL174930 0.85 RAB9A (0.52) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL175017 0.85 GAA (0.56) ALDH1A1MEN1KMT2ATSHRKDM4E
SCHEMBL175419 0.81 MAPT (0.54) MAPTMEN1KMT2AHTTRAB9A
SCHEMBL175262 0.81 SMN1; SMN2 (0.55) MAPTMEN1KMT2ATSHRKDM4E
SCHEMBL173846 0.78 STING1 (0.53) MAPTMEN1KMT2ALMNAHTT
SCHEMBL174986 0.78 KMT2A (0.52) MAPTMEN1KMT2ASAE1UBA2
Hydrochloric Acid SCHEMBL174066 0.77 KMT2A (0.51) MAPTMEN1KMT2ASAE1UBA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed